SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹12 Cr | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr |
What is the latest Consolidated Net Profit of SAKAR HEALTHCARE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹962,285 Cr |
How is Consolidated Net Profit of SAKAR HEALTHCARE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | -8.53 | |
| Mar2024 | ₹13 Cr | -15.95 | |
| Mar2023 | ₹15 Cr | 42.09 | |
| Mar2022 | ₹11 Cr | -100.00 | |
| Mar2021 | ₹962,285 Cr | - | |
Compare Consolidated Net Profit of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,690.8 Cr | -2.4% | 22.7% | 153.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -2.4% |
22.7% |
153.7% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses